Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for leukemia, acute lymphocytic, susceptibility to, 2 has been reported in the published literature.
No clinical trials have been registered for leukemia, acute lymphocytic, susceptibility to, 2.
75 publications have been identified in PubMed for leukemia, acute lymphocytic, susceptibility to, 2. Research spans Epidemiology / Natural History (31%), Basic Science / Preclinical (25%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 23 | 31% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:28 PM UTC
Online Mendelian Inheritance in Man
Laboratory research |
19 |
25% |
Patient case studies | 11 | 15% |
Research summaries | 9 | 12% |
Clinical study results | 6 | 8% |
Testing and diagnosis research | 4 | 5% |
New treatment approaches | 3 | 4% |
Madalese D (2026). [PMID: 42028798](https://pubmed.ncbi.nlm.nih.gov/42028798/). *HLA*. [Epidemiology / Natural History]
Álvarez-Carrasco P (2026). [PMID: 42064075](https://pubmed.ncbi.nlm.nih.gov/42064075/). *Front Immunol*. [Basic Science / Preclinical]
Sabbagh C (2026). [PMID: 41618027](https://pubmed.ncbi.nlm.nih.gov/41618027/). *Eur J Haematol*. [Epidemiology / Natural History]
Cao X (2026). [PMID: 41923653](https://pubmed.ncbi.nlm.nih.gov/41923653/). *Per Med*. [Epidemiology / Natural History]
Mason EJ (2026). [PMID: 41699110](https://pubmed.ncbi.nlm.nih.gov/41699110/). *Support Care Cancer*. [Clinical Trial Publication]
Song H (2026). [PMID: 41837192](https://pubmed.ncbi.nlm.nih.gov/41837192/). *Front Pediatr*. [Case Report / Case Series]
Meng X (2026). [PMID: 42089785](https://pubmed.ncbi.nlm.nih.gov/42089785/). *Cancer Epidemiol Biomarkers Prev*. [Epidemiology / Natural History]
Langie J (2026). [PMID: 41261530](https://pubmed.ncbi.nlm.nih.gov/41261530/). *HGG Adv*. [Gene Therapy / Novel Therapeutics]
Eriksen JVN (2026). [PMID: 41733102](https://pubmed.ncbi.nlm.nih.gov/41733102/). *Br J Haematol*. [Diagnostic / Biomarker]
Pegoraro F (2026). [PMID: 41881068](https://pubmed.ncbi.nlm.nih.gov/41881068/). *JCO Precis Oncol*. [Basic Science / Preclinical]